495 related articles for article (PubMed ID: 17366001)
1. Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus.
Mojiminiyi OA; Abdella NA
Scand J Clin Lab Invest; 2007; 67(2):215-25. PubMed ID: 17366001
[TBL] [Abstract][Full Text] [Related]
2. Plasma leptin concentration in patients with Type 2 diabetes: relationship to cardiovascular disease risk factors and insulin resistance.
Abdella NA; Mojiminiyi OA; Moussa MA; Zaki M; Al Mohammedi H; Al Ozairi ES; Al Jebely S
Diabet Med; 2005 Mar; 22(3):278-85. PubMed ID: 15717875
[TBL] [Abstract][Full Text] [Related]
3. Which obesity index best explains the link between adipokines, coronary heart disease risk and metabolic abnormalities in type 2 diabetes mellitus?
Mojiminiyi OA; Al Mulla F; Abdella NA
Med Princ Pract; 2009; 18(2):123-9. PubMed ID: 19204431
[TBL] [Abstract][Full Text] [Related]
4. Resistin - concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease.
Stejskal D; Adamovská S; Bartek J; Juráková R; Prosková J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2003 Nov; 147(1):63-9. PubMed ID: 15034607
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
[TBL] [Abstract][Full Text] [Related]
6. Relationships between human serum resistin, inflammatory markers and insulin resistance.
Bo S; Gambino R; Pagani A; Guidi S; Gentile L; Cassader M; Pagano GF
Int J Obes (Lond); 2005 Nov; 29(11):1315-20. PubMed ID: 16044175
[TBL] [Abstract][Full Text] [Related]
7. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
[TBL] [Abstract][Full Text] [Related]
8. Body iron stores in relation to the metabolic syndrome, glycemic control and complications in female patients with type 2 diabetes.
Mojiminiyi OA; Marouf R; Abdella NA
Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):559-66. PubMed ID: 18063352
[TBL] [Abstract][Full Text] [Related]
9. [Reduced resistin levels in patients with type 2 diabetes mellitus].
Yang J; Li M; Wu CY; Wang H; Xu QS; Deng JY
Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1471-4. PubMed ID: 14521723
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance and inflammation may have an additional role in the link between cystatin C and cardiovascular disease in type 2 diabetes mellitus patients.
Lee SH; Park SA; Ko SH; Yim HW; Ahn YB; Yoon KH; Cha BY; Son HY; Kwon HS
Metabolism; 2010 Feb; 59(2):241-6. PubMed ID: 19765773
[TBL] [Abstract][Full Text] [Related]
11. Fasting hyperinsulinemia associates with increased sub-clinical inflammation in first-degree relatives normal glucose tolerant women independently of the metabolic syndrome.
Setola E; Monti LD; Lucotti P; Galluccio E; Oldani M; Bosi E; Piatti P
Diabetes Metab Res Rev; 2009 Oct; 25(7):639-46. PubMed ID: 19685554
[TBL] [Abstract][Full Text] [Related]
12. Association of adiposity, inflammation and atherosclerosis: the role of adipocytokines and CRP in Asian Indian subjects.
Mahadik SR; Deo SS; Mehtalia SD
Metab Syndr Relat Disord; 2008 Jun; 6(2):121-8. PubMed ID: 18484906
[TBL] [Abstract][Full Text] [Related]
13. Serum resistin is positively correlated with the accumulation of metabolic syndrome factors in type 2 diabetes.
Osawa H; Ochi M; Tabara Y; Kato K; Yamauchi J; Takata Y; Nishida W; Onuma H; Shimizu I; Fujii Y; Miki T; Ohashi J; Makino H
Clin Endocrinol (Oxf); 2008 Jul; 69(1):74-80. PubMed ID: 18081734
[TBL] [Abstract][Full Text] [Related]
14. Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.
Zapolski T; Waciński P; Kondracki B; Rychta E; Buraczyńska MJ; Wysokiński A
Kardiol Pol; 2011; 69(4):319-26. PubMed ID: 21523662
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory markers, insulin resistance and carotid intima-media thickness in North-Indian type 2 diabetic subjects.
Ahmad J; Ahmned F; Siddiqui MA; Khan AR; Katyal P; Hameed B; Ahmad I
J Assoc Physicians India; 2007 Oct; 55():693-9. PubMed ID: 18173021
[TBL] [Abstract][Full Text] [Related]
16. Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity.
Hasegawa G; Ohta M; Ichida Y; Obayashi H; Shigeta M; Yamasaki M; Fukui M; Yoshikawa T; Nakamura N
Acta Diabetol; 2005 Jun; 42(2):104-9. PubMed ID: 15944845
[TBL] [Abstract][Full Text] [Related]
17. Resistin and adiponectin levels in subjects with coronary artery disease and type 2 diabetes.
Yaturu S; Daberry RP; Rains J; Jain S
Cytokine; 2006 May; 34(3-4):219-23. PubMed ID: 16822679
[TBL] [Abstract][Full Text] [Related]
18. Resistin is an inflammatory marker of inflammatory bowel disease in humans.
Konrad A; Lehrke M; Schachinger V; Seibold F; Stark R; Ochsenkühn T; Parhofer KG; Göke B; Broedl UC
Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1070-4. PubMed ID: 17998831
[TBL] [Abstract][Full Text] [Related]
19. Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adults.
Aquilante CL; Kosmiski LA; Knutsen SD; Zineh I
Metabolism; 2008 Apr; 57(4):494-501. PubMed ID: 18328350
[TBL] [Abstract][Full Text] [Related]
20. The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus.
Kadoglou NP; Iliadis F; Angelopoulou N; Perrea D; Ampatzidis G; Liapis CD; Alevizos M
Eur J Cardiovasc Prev Rehabil; 2007 Dec; 14(6):837-43. PubMed ID: 18043308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
